Annual Drug Patent Expiration for BYDUREON+BCISE
Bydureon Bcise is a drug marketed by Astrazeneca Ab and included in one NDA. It is available from a single supplier. There are fifteen patents protecting this drug.
Trends in the price of BYDUREON BCISE drugs.
Drug patent litigation for BYDUREON BCISE.
The generic ingredient in BYDUREON BCISE is exenatide synthetic. One registered supplier for this compound. Additional details are available on the exenatide synthetic profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in Recently expired patent for the drug Astrazeneca Ab BYDUREON BCISE